Drugs in MeSH Category Nicotinic Agonists
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Umedica | VARENICLINE TARTRATE | varenicline tartrate | TABLET;ORAL | 218985-002 | Jan 9, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hetero Labs Ltd Iii | VARENICLINE TARTRATE | varenicline tartrate | TABLET;ORAL | 214571-001 | Oct 23, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Alkem Labs Ltd | VARENICLINE TARTRATE | varenicline tartrate | TABLET;ORAL | 214557-002 | Aug 23, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Regcon Holdings | VARENICLINE TARTRATE | varenicline tartrate | TABLET;ORAL | 219106-001 | Oct 29, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
